XTLB
XTL Biopharmaceuticals Ltd. American Depositary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
XTL Biopharmaceuticals (XTLB) Stock: Buy, Sell, or Hold?
$1.60
-0.04 (-2.44%)
▼
5d:
+3.23%
30d:
-16.23%
90d:
-40.52%
QUANTITATIVE VERDICT
BUY
HIGH Confidence (95%)
Quality Score
58/100
Position
OVERSOLD
30-Day Fair Range
$1.67 – $2.00
Position: OVERSOLD
Wall Street Target
$30.00
+1775.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.52 / $2.10
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
✅ BUY SIGNAL: XTLB shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Get Alerted When XTLB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: XTLB is currently trading at $1.60, which is considered oversold relative to its 30-day fair value range of $1.67 to $2.00.
Technical Outlook: Technically, XTLB is in a strong downtrend. Immediate support is located at $1.52, while resistance sits at $2.10.
Market Sentiment: XTLB scores 94/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+1775.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XTLB is in a strong downtrend. Immediate support is located at $1.52, while resistance sits at $2.10.
Market Sentiment: XTLB scores 94/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+1775.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.67 -
$2.00
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$1.67 -
$2.00
Current vs Trading Range
OVERSOLD
Support Level
$1.52
Resistance Level
$2.10
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (94/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1775.0% below Wall St target ($30.00)
- BULLISH: Bottoming setup score 94/100 — corrected, stabilizing, and turning up
Fundamental Context
Wall Street Target
$30.00
(+1775.0%)
Earnings Growth (YoY)
-76.0%
Share XTLB Analysis
Share this live XTLB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 13, 2026 5:55 PM ET
Data refreshes hourly during market hours. Next update: 6:55 PM
Data refreshes hourly during market hours. Next update: 6:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XTLB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 41 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 37 SELL |
|
NAMS
NewAmsterdam Pharma Comp… |
STRONG BUY
16 analysts |
$50 | 55 HOLD |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 30 SELL |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$34 | 52 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive XTLB Research Pages